With successful trials, Roche takes its MS drug to regulators, but safety questions loom Approval could offset lost revenue from older therapy as company looks for its next blockbusters

https://www.statnews.com/2026/04/21/roche-multiple-scleroris-efficacy-safety/ By Andrew JosephApril 21, 2026 Europe Correspondent